Physician Knowledge and Awareness About Cardiac Amyloidosis in the Middle East and Gulf Region
JACC CardioOncol
.
2022 Sep 20;4(3):421-424.
doi: 10.1016/j.jaccao.2022.05.011.
eCollection 2022 Sep.
Authors
Firas Al Badarin
1
,
Khaldoon Al-Humood
2
,
Feras Bader
1
,
Said Alsaid
3
,
Kadhim Sulaiman
4
,
Matlooba Alzadjali
5
,
Hani Sabbour
1
,
Abdulla Shehab
6
,
Nooshin Bazargani
7
,
Stefano Perlini
8
Affiliations
1
Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
2
Al-Dabboos Cardiac Center, Kuwait City, Kuwait.
3
Alkindi Specialized Hospital, Bahrain, Manama.
4
Royal Hospital, Muscat, Oman.
5
International Specialized Center for Heart Disease, Oman.
6
Emirates Cardiac Society, Al-Ain, United Arab Emirates.
7
Dubai Health Authority, Dubai, United Arab Emirates.
8
Pavia Center for Cardiac Amyloidosis Research and Treatment, Pavia, Italy.
PMID:
36213353
PMCID:
PMC9537064
DOI:
10.1016/j.jaccao.2022.05.011
No abstract available
Keywords:
Middle East; cardiac amyloidosis; heart failure.
Publication types
Review